Recombinant viral vector for gene transfer into lymphoid cells
AssigneeThe Research Foundation for Microbial Diseases of Osaka University
InventorsYasuko Mori, Kenjiro Tadagaki, Masaya Takemoto, Michlaki Takahashi, Koichi Yamanishi
Life of this patent
Estimating the term…
Abstract
A recombinant herpesvirus, a method for producing the recombinant herpesvirus, and a pharmaceutical composition comprising the recombinant herpesvirus, are provided with a method for producing a recombinant herpesvirus using a BAC vector sequence. In addition, a vector comprising a herpesvirus genomic gene and a BAC vector sequence, a cell comprising the vector, and a nucleic acid cassette comprising a fragment, which is capable of homologous recombination with a herpesvirus genome, and a BAC vector sequence, are provided.
Claims2
A method for gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus comprising:
- a BAC vector sequence, wherein the BAC vector sequence is inserted into a non-essential region of a herpesvirus genome, and wherein the non-essential region is a non-essential region of HHV-7 or HHV-6.
A method for gene transfer comprising infecting a T lymphoid cell with a vector comprising:
- a human herpesvirus genome comprising an essential gene and a non-essential region, and
- a BAC vector sequence linked to the herpesvirus genome, wherein the BAC vector sequence is inserted into a non-essential region of the herpesvirus genome, and wherein the non-essential region is a non-essential region of HHV-7 or HHV-6.
Dependencies are inferred from the claim text.